John D. McDermott

Chief Executive Officer at Vascular Therapies, Inc.

John D. McDermott

John D. McDermott

Chief Executive Officer at Vascular Therapies, Inc.

Overview
Career Highlights

Bard Peripheral Vascular Technologies
Impra, Inc.
Vascular Therapies, Inc.

RelSci Relationships

642

Number of Boards

6

Birthday

1961

Age

60

Relationships
RelSci Relationships are individuals John D. McDermott likely has professional access to. A relationship does not necessarily indicate a personal connection.

Operating Partner, Palo Alto at Essex Woodlands Management, Inc.

Relationship likelihood: Strong

Former Vice President & General Manager, Worldwide Infection Prevention Business at Johnson & Johnson

Relationship likelihood: Strong

Former Chief Financial Officer at Ulthera, Inc.

Relationship likelihood: Strong

President at International Society of Endovascular Specialists

Relationship likelihood: Strong

Chief Scientific Officer & Director at Vascular Therapies, Inc.

Relationship likelihood: Strong

Chief Financial Officer, Director & Executive Vice President at DIH Technologies Co.

Relationship likelihood: Strong

Former President at Endologix LLC

Relationship likelihood: Strong

Chief Executive Officer at BlueWind Medical Ltd.

Relationship likelihood: Strong

Chief Executive Officer at TriVascular Technologies, Inc.

Relationship likelihood: Strong

Principal at Norwalk and Associates

Relationship likelihood: Strong

Paths to John D. McDermott
Potential Connections via
Relationship Science
You
John D. McDermott
Chief Executive Officer at Vascular Therapies, Inc.
Career History
Chief Executive Officer
2019 - Current

Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ.

President, Chief Executive Officer & Director
2016 - Prior

Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA.

Chief Executive Officer
2008 - 2018

Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

Transactions
Details Hidden

Vascular Therapies, Inc. raised money in a private placement transaction

Details Hidden

Endologix LLC raised money in a private placement transaction

Details Hidden

Endologix LLC raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John D. McDermott. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John D. McDermott's profile does not indicate a business or promotional relationship of any kind between RelSci and John D. McDermott.